Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 14, 2018 FBO #5955
SOLICITATION NOTICE

R -- Early Bactericidal Activity (EBA) of Anti-TB Drugs in India

Notice Date
3/12/2018
 
Notice Type
Presolicitation
 
NAICS
541690 — Other Scientific and Technical Consulting Services
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
000HCWGL-2018-18522
 
Archive Date
4/11/2018
 
Point of Contact
Linda F. Williams, Phone: 770-488-2692
 
E-Mail Address
luw9@cdc.gov
(luw9@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
Department of Health and Human Services, Centers for Disease Control and Prevention, Office of Financial Resources, Office of Acquisition Services, Room 3000, 2920 Brandywine Road, Atlanta, GA 30341-3724 The Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH) Division of Global HIV & Tuberculosis (DGHT), Global TB Prevention and Control Branch, intends to negotiate a sole source contract with National Institute for Research in Tuberculosis (NIRT), India for technical support services for the implementation of a small early bacterial activity (EBA) study in Chennai, India. The implementation of EBA of anti-TB drugs study will generate the evidence needed to fill a specific gap in CDC's knowledge about treatment of drug-resistant TB to inform practice recommendations for the control and prevention of drug-resistant TB. The National Institute for Research in Tuberculosis (NIRT) in Chennai, India, is the only governmental institution in India with the experience and trained staff to conduct clinical trials in tuberculosis patients, including drug-resistant tuberculosis. NIRT is also the only governmental organization that has established working relationship with clinical centers or facilities in Chennai, India, that can consent, enroll, diagnose, treat, and monitor patients, collect and store sputum specimens for research purposes, and maintain meticulous records. NIRT also has established and validated laboratory procedures for the proposed EBA study, in addition to reference-laboratory level routine microbiological and molecular procedures: overnight sputum collection and logistics, quantitative cultures on Middlebrook 7H11S agar plates per SOP, quantitative cultures in MGIT 960 per SOP, phenotypic drug susceptibility testing, and genotypic drug susceptibility testing with line probe assay (LPA) for isoniazid, rifampicin, fluroquinolones, and aminoglycosides. NIRT also has an established institutional ethics committee to review and approve the research protocol specified, and to obtain all the necessary government of India approvals. The justification for this non-competitive action is in accordance with 13.106-1(b)(1), only one source is reasonably available which states that, "For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available. This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a Capability Statement demonstrating their abilities to meet this requirement. All responses will be considered. All Capability Statements shall be received by the closing date of this synopsis and shall be submitted in writing. Responses may be sent via email to luw9@cdc.gov. No solicitation will be issued. No telephone inquiries will be accepted.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/000HCWGL-2018-18522/listing.html)
 
Place of Performance
Address: The National Institute for Research in Tuberculosis (NIRT) in Chennai, India, India
 
Record
SN04850538-W 20180314/180312230842-c41ed68aabc86be5244ba94ae36f16f2 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.